FDA's CME POLICY IS RIPE FOR REVIEW IN D.C. FEDERAL COURT: JUDGE LAMBERTH REJECTS FDA ATTEMPT TO DISMISS WLF SUIT; ATTEMPT TO REGULATE BY DRAFT RULE IRKS JUDGE
Executive Summary
FDA's "draft policy statement" on continuing medical education is having the regulatory impact of a final agency rule and can be challenged in court for its effect on free speech, D.C. federal court judge Royce Lamberth declared in a March 9 preliminary decision in the Washington Legal Foundation v. Kessler.